Physician profile
Jaspreet Singh
NPI 1417105123
$2,155.54
in general payments reported to CMS, 2019-2025
13 companies · $540 in 2025
The $540 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2021: $85.67 · 2022: $132 · 2023: $757 · 2024: $491 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $805.93 | 2022-2025 | Titan |
| Medtronic, INC. | $521.13 | 2021-2024 | Endoflip, Gi Genius |
| Olympus America INC. | $181.34 | 2021-2025 | Single Use Repositionable Clip, Gastrointestinal Videoscope |
| Boston Scientific Corporation | $160.81 | 2020-2025 | Apollo Esg Nxt System, Exalt Model D |
| Steris Corporation | $127.14 | 2025 | |
| Philips North America LLC | $105.95 | 2020 | |
| Merck Sharp & Dohme LLC | $73.97 | 2021-2025 | Keytruda, Keytruda Qlex |
| Fujifilm Healthcare Americas Corporation | $49.76 | 2024 | |
| Conmed Corporation | $42.34 | 2020-2024 | Conmed Biliary |
| Janssen Biotech, INC. | $23.62 | 2025 | Simponi, Stelara, Tremfya |
| Teleflex LLC | $22.75 | 2025 | Barrigel |
| Astrazeneca Pharmaceuticals LP | $21.62 | 2024 | Saphnelo |
| 180 Medical, INC. | $19.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaspreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.